MISAA, LLC commenced FDA process for patent pending, tacroli

MISAA, LLC commenced FDA process for patent pending, tacrolimus enhanced lateral flow assay

/PRNewswire/ -- MISAA and IOS are pleased to announce they have commenced the FDA certification process for the patent pending, tacrolimus immunosuppressant in...

Related Keywords

Reuben Sandler , Intelligent Optical Systems Inc , Intelligent Optical Systems , Lateral Flow Assay , Optical Systems ,

© 2025 Vimarsana